Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 7,385 shares at an average $21.55 ($159,136)
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 8-K Event Executive or director change
  12. SCHEDULE 13D/A Stake Beneficial Ownership Report
  13. 10-K Report Annual Report
  14. 8-K Event Results of operations
  15. 4 Open-market sale EVP, CHIEF LEGAL OFFICER, SEC sold 6,950 shares at $23.38 ($162,491)
  16. 8-K Event Results of operations · Regulation FD disclosure
  17. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 10,262 shares at $23.69 ($243,114)
  18. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 4,084 shares at $23.69 ($96,754)
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. 4 Open-market sale Director sold 30,000 shares at $22.37 ($670,983)

Page 3 of 70 · 1,382 filings